BRIEF

on Justera Health Ltd. (CVE:VTAL)

Justera Health Announces Sale of Subsidiary and Leadership Changes

Justera Health Ltd. has announced a definitive agreement to sell its subsidiary, Port North Extracts Inc., to 2657953 Ontario Inc. The sale includes all issued and outstanding shares for $1, and the purchaser assumes all of Port North's liabilities. No finder's fee is associated with this transaction. This was formalized on February 26, 2026, pending customary conditions.

Furthermore, Justera's CEO, Joshua Herman, and CFO, Paul Haber, have both resigned. The company acknowledged their leadership and contributions. Young Cho Lee remains as the sole director and officer.

R. E.

Copyright © 2026 FinanzWire, all reproduction and representation rights reserved.
Disclaimer: although drawn from the best sources, the information and analyzes disseminated by FinanzWire are provided for informational purposes only and in no way constitute an incentive to take a position on the financial markets.

Click here to consult the press release on which this article is based

See all Justera Health Ltd. news